Flu Vaccine Shows Effectiveness Despite A(H3N2) Variants
Tap title to read story
Interim estimates show the 2024-25 influenza vaccine was effective in preventing influenza-related illness in the US, with varying efficacy (32-78%) across age groups and settings. While effectiveness against A(H3N2) was lower and similar to previous years, the overall findings are consistent with Canada and South America. Despite limitations like preliminary data and potential misclassification, the CDC emphasizes vaccination as crucial for preventing influenza and associated hospitalizations, recommending vaccination for all those aged 6 months and older.
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.